Timothy Schell: Leading the FDA's Veterinary Efforts

Timothy Schell is a prominent figure in the field of veterinary medicine, currently serving as the acting director of the FDA's Center for Veterinary Medicine. His leadership is pivotal in the agency's efforts to address the challenges faced by the nation's livestock industry.

Current Role

In his capacity as acting director, Schell is responsible for overseeing the review and approval process of animal drugs. This role is particularly significant as the FDA continues to expedite these reviews to combat threats to livestock and, by extension, the livelihoods of farmers and ranchers across the United States.

Impact and Initiatives

Schell has been vocal about the FDA's commitment to supporting the agricultural sector through timely and effective drug approvals. This initiative is aimed at ensuring the health and productivity of livestock, which is a critical component of the U.S. economy and food supply chain. Schell emphasized the commitment to ensuring the safety and effectiveness of animal drugs.

Modified: 2025/12/30

---